Semaglutide cuts MUC5AC mucin in cell and mouse airway model
Researchers compared six GLP-1 receptor agonists and two PPAR-gamma agonists against pyocyanin-driven mucus hypersecretion, with effects blocked by Exendin(9-39).
PR
By Priya Raman · Science Reporter
Sep 6 20:00 ETSource: Frontiers in immunology
The wire
- 01In Frontiers in Immunology, semaglutide and pioglitazone were most effective at lowering MUC5AC expression and reactive oxygen species in bronchial cells and C57BL/6 mice exposed to Pseudomonas aeruginosa pyocyanin.
- 02The authors frame repurposed semaglutide as a possible adjunct in COPD, a use well outside current metabolic indications clinicians see.
- 03Work is confined to cell cultures and a mouse chronic bronchitis model; no human data support an airway indication.
From the source
Read at pubmed.ncbi.nlm.nih.govSemaglutide and pioglitazone restore airway mucosal homeostasis by resolving Pseudomonas aeruginosa pyocyanin-induced mucus hypersecretion, ciliostasis, and type 2 airway inflammation
Frontiers in immunology · 2026 · Wu C, Kulkarni NA, Lew SQ et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42769032/